Prevention of IDDM: A public health perspective

Diabetes Research and Clinical Practice

Volumn 34, Issue SUPPL., 1996, Pages

  Marrero, David G ^a,b   Kraft, Stephanie Kakos ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Diabet Research and Training Center   (United States)

Author keywords

insulin dependent diabetes mellitus; prevention; risk factors

Indexed keywords

CONFERENCE PAPER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; REHABILITATION; RISK FACTOR; SECONDARY PREVENTION;

EID: 0030499654     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)01323-X     Document Type: Conference Paper

References (17)

1. Hagopian, W.A., Kaliappan, S.B., Knip, M., Schiffrin, A., Miyao, N. and Soeldner, J.S. (1994) Evolution of autoantibodies to glutamate decarboxylase (GAD65ab), insulin (IAA) and islet cell antibodies (ICA) in prediabetes. Diabetes 43(Suppl. 1).
2. The Diabetes Prevention Group (194) The diabetes prevention trial of Type 1 diabetes. Diabetes 43(Suppl. 1).
3. Vinicor, F. (1994) Is diabetes a public-health disorder? Diabetes Care 17(Suppl. 1), 22-27.
4. National Center for Health Statistics (1992) Current estimates from the National Health Interview Survey, 1991. In: Vital and Health Statistics. Washington, DC, U.S. Govt. Printing Office, (Ser. 10, no. 184).
5. Harris, M.I. (Ed.) Diabetes in America. Bethesda, MD: The U.S. Department of Health and Human Services, National Institutes of Health Publication No. 85-1468, August, 1985.
6. Reiber, G.E. (1992) Diabetic foot care: financial implications and practice guidelines. Diabetes Care 15 (Suppl. 1), 29-31.
7. Herman, W. (Ed.) (1991) The Prevention and Treatment of Complications of Diabetes: a Guide for Primary Care Practitioners. Atlanta, GA: The U.S. Department of Health and Human Services, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation.
8. Rubin, R.J., Altman, W.M. and Mendelson, D.N. (1994) Health expenditures for people with diabetes mellitus, 1992. J. Clin. Endocrinol. Metab. 78(4), 809a-809f.
9. Olsson, J., Persson, U., Tollin, C., Nilsson, S. and Melander A. (1994) Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care 17(11), 1257-1263.
10. Patterson, C.C., Carson, D.J., Hadden, D.R., Waugh, N.R. and Cole, S.K. (1994) A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 17(5), 376-381.
11. Diabetes Epidemiology Research International (1887) Preventing insulin-dependent diabetes mellitus: the environmental challenge. Br. Med. J. 295, 479-481.
12. Dahlquist, G. and Kallen, B. (1992) Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset Type I (insulin-dependent) diabetes mellitus. Diabetologia 35, 671-675.
13. Sachs, J.A., Cudworth, A.G., Jaraquemada, D., Gorsuch, A.N. and Festenstein, H. (1980) Type I diabetes and the HLA-D locus. Diabetologia 18, 41-43.
14. Karjalainen, J., Salmela, P., Ilonen, J., Surcel, H.M. and Knip, M. (1989) A comparison of childhood and adult Type I diabetes mellitus. N. Engl. J. Med. 320, 881-886.
15. Svejgaard, A., Jakobsen, B.K., Platz, P. et al. (1986) HLA associations in insulin-dependent diabetes: search for heterogenity in different groups of patients from a homogenous population. Tissue Antigens 28, 237-244.
16. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
17. Lewis, E.J., Hunsicker, L.G., Bain, R.P. and Rohde, R.D. (1993) The effect of angiostensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329, 1456-1462.